Subscribe to Newsletter
Subspecialties Cornea / Ocular Surface

Benchmarking Cornea Clinical Trials

The cornea is no stranger to innovation and research – an incredible amount of time, effort and money has been invested in refractive surgery R&D over the years, and such procedures are almost uniformly safe and successful. But there’s more to the cornea than being a refractive surface that’s ripe for ablation – it’s the site of many diseases, from ocular surface disorders to endothelial dystrophies and everything in between. Treatment strategies span everything from excimer and femtosecond laser interventions, UV illumination combined with riboflavin application, stem cells, to even the topical administration fungal isolates like ciclosporin.

So what’s next? To find out where clinical research into dry eye has been focused, and where ongoing clinical trials might take the field, we performed an analysis of dry eye clinical trials on

We searched for: “cornea,” and analyzed the data in Microsoft Excel 2013. Inappropriate records were excluded, and the full text of each record examined for additional details to be recorded into the spreadsheet.

Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

About the Author
Mark Hillen

I spent seven years as a medical writer, writing primary and review manuscripts, congress presentations and marketing materials for numerous – and mostly German – pharmaceutical companies. Prior to my adventures in medical communications, I was a Wellcome Trust PhD student at the University of Edinburgh.

Related Case Studies
The Missing Piece of the Dry Eye Puzzle

| Contributed by Quidel

Uncovering Ocular Comorbidity

| Contributed by Quidel

Finding Ocular Surface Inflammation

| Contributed by Quidel

Related Product Profiles
Subspecialties Cornea / Ocular Surface
Tear Osmolarity – Empowering. Established. Essential.

| Contributed by TearLab

Subspecialties Cornea / Ocular Surface
Preservative-Free Cyclosporine 0.1% Ophthalmic Emulsion

| Contributed by ImprimisRx

Product Profiles

Access our product directory to see the latest products and services from our industry partners

Most Popular
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine



The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: